<HTML>
<HEAD>
<meta name="HTML_Retention_Review_Frequency" content="">
<meta name="HTML_Last_Reviewed_Date" content="">
<meta name="HTML_Retention_Period_Start_Date" content="11/5/2010">
<meta name="HTML_Initial_Creation_Date" content="02 Nov 2010 15:30:34 -0400">
<meta name="HTML_Record_Title_ID" content="72">
<meta name="HTML_Information_Classification" content="NONE">
<meta name="HTML_Content_Steward" content="Fradette S u072008">
<META NAME="Generator" CONTENT="Microsoft Word 97">
<TITLE>Form S-8</TITLE>
<META NAME="Content_Steward" CONTENT="Fradette S u072008">
<META NAME="Retention_Period_Start_Date" CONTENT="4/1/2004">
<META NAME="Information_Classification" CONTENT="NONE">
<META NAME="Record_Title_ID" CONTENT="72">
<META NAME="Initial_Creation_Date" CONTENT="5/3/2005 11:49:00 AM">
</HEAD>
<BODY>

<B><FONT FACE="Courier"><P ALIGN="CENTER">UNITED STATES</P>
<P ALIGN="CENTER">SECURITIES AND EXCHANGE COMMISSION</P>
</B><P ALIGN="CENTER">WASHINGTON, D.C. 20549</P>
<P ALIGN="CENTER">____________________</P>

<B><P ALIGN="CENTER">Form S-8</P>
</B><P ALIGN="CENTER">REGISTRATION STATEMENT </P>
<P ALIGN="CENTER">under</P>
<P ALIGN="CENTER">THE SECURITIES ACT OF 1933</P>
<P ALIGN="CENTER">____________________</P>

<B><P ALIGN="CENTER">THE DOW CHEMICAL COMPANY</P>
<P ALIGN="CENTER">(a Delaware corporation)</P>
</B><P ALIGN="CENTER">Executive Offices -- 2030 Dow Center</P>
<P ALIGN="CENTER">Midland, Michigan 48674</P>
<P ALIGN="CENTER"></P>
<I><P ALIGN="CENTER">(Name, state of incorporation and address of principal executive office of issuer)</P>
</I><P ALIGN="CENTER"></P>
<P ALIGN="CENTER">I.R.S. Employer Identification No. 38-1285128</P>
<P ALIGN="CENTER">____________________</P>
<B><P ALIGN="CENTER"></P>
<P ALIGN="CENTER">The Dow Chemical Company</P>
<P ALIGN="CENTER">2003-2013 Employees' Stock Purchase Plan</P>
</B><I><P ALIGN="CENTER">(Full title of the plan)</P>
</I><P ALIGN="CENTER">____________________</P>
<B><P ALIGN="CENTER"></P>
</B><P ALIGN="CENTER">CHARLES J. KALIL</P>
<P ALIGN="CENTER">Executive Vice President, General Counsel</P>
<P ALIGN="CENTER">and Corporate Secretary</P>
<P ALIGN="CENTER">THE DOW CHEMICAL COMPANY</P>
<P ALIGN="CENTER">2030 Dow Center</P>
<P ALIGN="CENTER">Midland, Michigan 48674</P>

<I><P ALIGN="CENTER">(Name and address of agent for service)</P>
</I><P ALIGN="CENTER">Telephone:  (989) 636-1000</P>
<P ALIGN="CENTER">____________________</P>

<B><P ALIGN="CENTER">CALCULATION OF REGISTRATION FEE</P>
<P ALIGN="CENTER"></P></B></FONT>
<TABLE BORDER CELLSPACING=2 CELLPADDING=9 WIDTH=885 DIR="LTR">
<TR><TD WIDTH="28%" VALIGN="TOP">
<FONT FACE="Courier"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Title </P>
<P ALIGN="CENTER">of securities </P>
<P ALIGN="CENTER"> to be registered</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<FONT FACE="Courier"><P ALIGN="CENTER"></P>
<P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Amount to</P>
<P ALIGN="CENTER"> be registered</FONT></TD>
<TD WIDTH="15%" VALIGN="TOP">
<FONT FACE="Courier"><P ALIGN="CENTER">Proposed maximum</P>
<P ALIGN="CENTER">offering price</P>
<P ALIGN="CENTER">per share</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP">
<FONT FACE="Courier"><P ALIGN="CENTER">Proposed maximum</P>
<P ALIGN="CENTER">aggregate</P>
<P ALIGN="CENTER">offering price</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP">
<FONT FACE="Courier"><P ALIGN="CENTER"></P>
<P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Amount of</P>
<P ALIGN="CENTER">registration fee</FONT></TD>
</TR>
<TR><TD WIDTH="28%" VALIGN="TOP">
<FONT FACE="Courier"><P ALIGN="CENTER">Common Stock, par value $2.50 per share, of The Dow Chemical Company</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<FONT FACE="Courier"><P ALIGN="CENTER">12,000,000<BR>
shares</FONT></TD>
<TD WIDTH="15%" VALIGN="TOP">
<FONT FACE="Courier"><P ALIGN="CENTER">$25.75</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP">
<FONT FACE="Courier"><P ALIGN="CENTER">$309,000,000</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP">
<FONT FACE="Courier"><P ALIGN="CENTER">$22,031.70</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Courier"><P ALIGN="CENTER"></P>
<P ALIGN="CENTER">PART II</P>

<B><P>Item 3.  INCORPORATION OF DOCUMENTS BY REFERENCE.</P>
</B>
<P ALIGN="JUSTIFY">&#9;The following documents heretofore filed by The Dow Chemical Company (&quot;Dow&quot;) with the Securities and Exchange Commission (the
&quot;Commission&quot;) are incorporated herein by this reference:</P>
<P ALIGN="JUSTIFY">(a)</FONT><FONT SIZE=2>  </FONT><FONT FACE="Courier">Dow's Annual Report on Form 10-K for the year ended December 31, 2009. (The consolidated financial statements and the related financial statement schedule, incorporated by reference from Dow's Annual Report on Form 10-K, filed February 19, 2010, and Dow's internal control over financial reporting have been audited by Deloitte &amp; Touche LLP, an independent registered public accounting firm, as stated in their reports, which are incorporated herein by reference.)</P>
<P ALIGN="JUSTIFY">(b)  Dow's Quarterly Reports on Form 10-Q for the quarters ended March 31, 2010, June 30, 2010 and September 30, 2010.</P>
<P ALIGN="JUSTIFY">(c)  Dow's Current Reports on Form 8-K filed or furnished, as the case may be, on February 2, 2010, February 11, 2010, February 12, 2010, February 18, 2010, February 19, 2010, March 9, 2010, April 28, 2010, May 3, 2010, May 14, 2010, June 10, 2010, August 3, 2010 and October 28, 2010.</P>
<P ALIGN="JUSTIFY">&#9;(d)&#9;The description of Dow's Common Stock, par value $2.50 per share, contained in a registration statement filed pursuant to Section 12 of the Securities Exchange Act of 1934 (the Act) and any amendments or reports filed for the purpose of updating that description.</P>
<P ALIGN="JUSTIFY">&#9;All documents subsequently filed by Dow pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Act prior to the filing of a post-effective amendment which indicates that all the securities offered hereby have been sold or which deregisters all such securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents.</P>
<P ALIGN="JUSTIFY">&#9;&nbsp;</P>
<B><DIR>

<P>Item 5.  INTERESTS OF NAMED EXPERTS AND COUNSEL.</P>
</DIR>

</B><P ALIGN="JUSTIFY">&#9;The validity of the issuance of Dow's Common Stock offered hereby has been passed on by Duncan A. Stuart, Associate General Counsel - Corporate Transactions for Dow.  As of November 1, 2010, Mr. Stuart beneficially owned 8,250 deferred stock units and 15.6 shares of Dow common stock pursuant to various employee stock plans; and held options to purchase 71,211 shares of Dow common stock, of which options to purchase 42,256 shares of Dow common stock were exercisable.</P>
<P ALIGN="JUSTIFY"></P>
<B>
<P>Item 6.  INDEMNIFICATION OF DIRECTORS AND OFFICERS.</P>
</B>
<P ALIGN="JUSTIFY">Under Article&nbsp;VI of the Restated Certificate of Incorporation, as amended, Dow may indemnify its Directors, officers, employees and agents to such extent as is permitted by the laws of the State of Delaware and as Dow's Bylaws may from time to time provide.  Section&nbsp;145 of the General Corporation Law of the State of Delaware empowers Dow to indemnify, subject to the standards and limitations therein prescribed, any person in connection with any action, suit or proceeding brought or threatened by reason of the fact that such person is or was a Director, officer, employee or agent of Dow or is or was serving as such with respect to another corporation or other enterprise at the request of Dow.  Under Section&nbsp;VI of the Bylaws of Dow, Dow is required to indemnify its Directors, officers and employees to the fullest extent permitted by Delaware law whenever such a person is a defendant in any legal proceeding.  Section&nbsp;VI also gives the Company discretion to indemnify Directors, officers, employees and agents in other legal proceedings to which they are made a party.  Any indemnification of a Director, officer, employee or agent of the Company must be approved by the Board of Directors.  Dow maintains a Directors' and officers' liability insurance policy that indemnifies Dow's Directors and officers against certain losses in connection with claims made against them for certain wrongful acts.</P>

<P>&nbsp;</P>
<B>
<P>Item 8.  EXHIBITS.</P>
</B></FONT>
<TABLE BORDER CELLSPACING=1 CELLPADDING=9 WIDTH=738 DIR="LTR">
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>Exhibit No.</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>Description of Exhibit</P>
</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>4(a)</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>Restated Certificate of Incorporation of The Dow Chemical Company, filed as Exhibit 3(i) to Dow's Quarterly Report on Form 10-Q for the quarter ended September 30, 2010, incorporated herein by this reference.</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>4(a)(i)</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>Certificate of Designations for the Cumulative Convertible Perpetual Preferred Stock, Series A, as originally filed with the Secretary of State, State of Delaware on March 31, 2009, and re-filed on May 17, 2010, incorporated by reference to Exhibit 3.1 to The Dow Chemical Company Current Report on Form 8-K filed on April 1, 2009.</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>4(b)</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>Bylaws of The Dow Chemical Company, filed as Exhibit 99.1 to a Form 8-K filed on February 12, 2010, incorporated herein by this reference.</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>5</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>Opinion of Counsel</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>23(a)</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>Consent of Independent Registered Public Accounting Firm.</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>23(b)</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>ARPC's Consent.</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>23(c)</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>Consent of Duncan A. Stuart, included in the opinion filed as Exhibit 5.</FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>24</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Courier"><P>Power of Attorney.</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Courier">
<P>&nbsp;</P>
<B><P>Item 9.  UNDERTAKINGS.</P>
</B>
<P ALIGN="JUSTIFY">(a)  The undersigned registrant hereby undertakes:</P>
<P ALIGN="JUSTIFY">&#9;(1)&#9;To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</P>
<P ALIGN="JUSTIFY">(i)&#9;To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;</P>
<P ALIGN="JUSTIFY">(ii)&#9;To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement; and</P>
<P ALIGN="JUSTIFY">(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;</P>

<P ALIGN="JUSTIFY">&#9;Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.</P>
<P ALIGN="JUSTIFY">&#9;(2)&#9;That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</P>
<P ALIGN="JUSTIFY">&#9;(3)&#9;To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</P>

<P ALIGN="JUSTIFY">(b)&#9;The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</P>

<P ALIGN="JUSTIFY">(c)&#9;Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to Directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable.  In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a Director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such Director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.</P>

<P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="CENTER">SIGNATURES</P>
<P>&#9;The Registrant.  Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Midland, State of Michigan, on November 3, 2010.</P>

<P>&nbsp;</P>
<P>&#9;&#9;&#9;&#9;&#9;    THE DOW CHEMICAL COMPANY</P>
<P>                             (Registrant)                                           </P>
<P ALIGN="RIGHT">&nbsp;</P>
<P>&#9;&#9;&#9;&#9;&#9;    By: <U>/S/ RONALD C. EDMONDS</P>
</U><P>&#9;&#9;&#9;&#9;&#9;&#9;   Ronald C. Edmonds</P>
<P>Vice President and Controller</P>

<P>Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.</P>
<p><u>A. A. ALLEMANG*</u></p>
<p>A. A. Allemang&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Director</p>
<p><u>J. K. BARTON*</u></p>
<p>J. K. Barton&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Director</p>
<p><u>J. A. BELL*</u></p>
<p>J. A. Bell&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Director</p>
<p><u>J. M. FETTIG*</u></p>
<p>J. M. Fettig&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Director</p>
<p><u>B. H. FRANKLIN*</u></p>
<p>B. H. Franklin&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Director</p>
<p><u>J. B. HESS*</u></p>
<p>J. B. Hess&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Director</p>
<p><u>A. N. LIVERIS*</u></p>
<p>A. N. Liveris&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Director, President, Chief Executive Officer and
Chairman</p>
<p>______________</p>
<p>P. Polman&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Director</p>
<p><u>D. H. REILLEY*</u></p>
<p>D. H. Reilley&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Director</p>
<p><u>J. M. RINGLER*</u></p>
<p>J. M. Ringler&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Director</p>
<p><u>R. G. SHAW*</u></p>
<p>R. G. Shaw&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Director</p>
<p><u>P. G. STERN*</u></p>
<p>P. G. Stern&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Presiding Director</p>
<p><u>/S/ R. C. EDMONDS</u></p>
<p>R. C. Edmonds&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vice President and Controller </p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Principal Accounting Officer)</p>
<p><u>W. H. WEIDEMAN*</u></p>
<p>W. H. Weideman&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Executive Vice President and Chief Financial Officer</p>
<p>&nbsp;</p>
<p>*By: <u>/S/ RONALD C. EDMONDS</p>
</u>
<p>Ronald C. Edmonds</p>
<p>Attorney-in-Fact</p>
<p>November 3, 2010</p>
<P>&nbsp;</P>
<U></U>
<B><P ALIGN="CENTER">EXHIBIT INDEX</P>
</B></FONT>
<TABLE BORDER CELLSPACING=1 CELLPADDING=9 WIDTH=738 DIR="LTR">
<TR><TD WIDTH="22%" VALIGN="TOP">
<FONT FACE="Courier"><P>Exhibit No.</FONT></TD>
<TD WIDTH="65%" VALIGN="TOP">
<FONT FACE="Courier"><P>Description of Exhibit</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Courier"><P>Page Number</FONT></TD>
</TR>
<TR><TD WIDTH="22%" VALIGN="TOP">
<FONT FACE="Courier"><P>4(a)</FONT></TD>
<TD WIDTH="65%" VALIGN="TOP">
<FONT FACE="Courier"><P>Restated Certificate of Incorporation of The Dow Chemical Company, filed as Exhibit 3(i) to Dow's Quarterly Report on Form 10-Q for the quarter ended September 30, 2010, incorporated herein by this reference.</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="22%" VALIGN="TOP">
<FONT FACE="Courier"><P>4(a)(i)</FONT></TD>
<TD WIDTH="65%" VALIGN="TOP">
<FONT FACE="Courier"><P>Certificate of Designations for the Cumulative Convertible Perpetual Preferred Stock, Series A, as originally filed with the Secretary of State, State of Delaware on March 31, 2009, and re-filed on May 17, 2010, incorporated by reference to Exhibit 3.1 to The Dow Chemical Company Current Report on Form 8-K filed on April 1, 2009.</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="22%" VALIGN="TOP">
<FONT FACE="Courier"><P>4(b)</FONT></TD>
<TD WIDTH="65%" VALIGN="TOP">
<FONT FACE="Courier"><P>Bylaws of The Dow Chemical Company, filed as Exhibit 99.1 to a Form 8-K filed on February 12, 2010, incorporated herein by this reference.</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="22%" VALIGN="TOP">
<FONT FACE="Courier"><P>5</FONT></TD>
<TD WIDTH="65%" VALIGN="TOP">
<FONT FACE="Courier"><P>Opinion of Counsel</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Courier"><P ALIGN="CENTER">10-11</FONT></TD>
</TR>
<TR><TD WIDTH="22%" VALIGN="TOP">
<FONT FACE="Courier"><P>23(a)</FONT></TD>
<TD WIDTH="65%" VALIGN="TOP">
<FONT FACE="Courier"><P>Consent of Independent Registered Public Accounting Firm.</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Courier"><P ALIGN="CENTER">12</FONT></TD>
</TR>
<TR><TD WIDTH="22%" VALIGN="TOP">
<FONT FACE="Courier"><P>23(b)</FONT></TD>
<TD WIDTH="65%" VALIGN="TOP">
<FONT FACE="Courier"><P>ARPC's Consent.</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Courier"><P ALIGN="CENTER">13</FONT></TD>
</TR>
<TR><TD WIDTH="22%" VALIGN="TOP">
<FONT FACE="Courier"><P>23(c)</FONT></TD>
<TD WIDTH="65%" VALIGN="TOP">
<FONT FACE="Courier"><P>Consent of Duncan A. Stuart, included in the opinion filed as Exhibit 5.</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="22%" VALIGN="TOP">
<FONT FACE="Courier"><P>24</FONT></TD>
<TD WIDTH="65%" VALIGN="TOP">
<FONT FACE="Courier"><P>Power of Attorney.</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Courier"><P ALIGN="CENTER">14-15</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Courier"><P ALIGN="CENTER"></P>
<P ALIGN="CENTER">EXHIBIT 5</P>
<P ALIGN="CENTER">OPINION OF COUNSEL</P>
<P ALIGN="CENTER"></P>
<P ALIGN="JUSTIFY">November 5, 2010</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">The Dow Chemical Company</P>
<P ALIGN="JUSTIFY">2030 Dow Center</P>
<P ALIGN="JUSTIFY">Midland, Michigan  48674</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">Ladies and Gentlemen:</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">I am Associate General Counsel - Corporate Transactions of The Dow Chemical Company, a Delaware corporation (the
&quot;Company&quot;).  Reference is hereby made to the Registration Statement on Form S-8 filed by the Company on the date hereof with the Securities and Exchange Commission, relating to the registration of
12 million shares of the Company's common stock, par value $2.50 per share (the
&quot;Common Stock&quot;), for The Dow Chemical Company 2003-2013 Employees' Stock Purchase Plan (the
&quot;Plan&quot;). </P>
<P ALIGN="JUSTIFY">In rendering the opinions expressed below, I have supervised the examination of: (a) the Restated Certificate of Incorporation of the Company and all amendments thereto; (b) the Bylaws of the Company and all amendments thereto; (c) the Registration Statement on Form S-8; (d) resolutions of the Board of Directors of the Company; and (e) such other documents, corporate records and instruments as I have deemed necessary or advisable for the purpose of this opinion.</P>
<P ALIGN="JUSTIFY">Based on the foregoing, and subject to the qualifications hereinafter set forth, it is my opinion that:</P>
<DIR>

<P ALIGN="JUSTIFY">1. The Company is duly organized and existing under the laws of the State of Delaware; and</P>
<P ALIGN="JUSTIFY">2. The Common Stock to be issued pursuant to the Plan is duly authorized for issuance and, when issued and delivered, will be legally issued, fully paid and nonassessable.</P>
</DIR>

<P ALIGN="JUSTIFY">I do not express any opinion concerning matters under or involving any law other than the law of the State of Michigan, the General Corporation Law of the State of Delaware and applicable federal law of the United States of America.  The opinions expressed herein are based upon the laws in effect on the date hereof, and I assume no obligation to revise or supplement this opinion should such laws be changed by legislative action, judicial decision or otherwise.</P>
<P ALIGN="JUSTIFY">I hereby consent to the filing of this opinion as an exhibit to the Company's Registration Statement on Form S-8 and to the reference to me under the caption
&quot;Interests of Named Experts and Counsel in the Registration Statement&quot;.</P>
<P>Very truly yours,</P>
<P>&#9;&#9;&#9;&#9;&#9;</P>

<U><P>/S/ DUNCAN A. STUART</P>
</U><P>Duncan A. Stuart</P>
<P>Associate General Counsel -</P>
<P>Corporate Transactions</P>
<P>The Dow Chemical Company</P>

<P>&nbsp;</P>
<P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">EXHIBIT 23(a)</P>
<P ALIGN="CENTER"></P>
<P>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</P>

<P ALIGN="JUSTIFY">We consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports dated February 19, 2010, relating to the financial statements and financial statement schedule of The Dow Chemical Company and subsidiaries (the
&quot;Company&quot;), and the effectiveness of the Company's internal control over financial reporting, appearing in the Annual Report on Form 10-K of The Dow Chemical Company for the year ended December 31, 2009.</P>

<P ALIGN="JUSTIFY">&nbsp;</P>
</FONT>
<TABLE BORDER CELLSPACING=1 CELLPADDING=9 WIDTH=332 DIR="LTR">
<TR><TD VALIGN="TOP" HEIGHT=22>
<FONT FACE="Courier"><P>/S/ DELOITTE &amp; TOUCHE LLP</FONT></TD>
</TR>
<TR><TD VALIGN="TOP" HEIGHT=22>
<FONT FACE="Courier"><P>Midland, Michigan</FONT></TD>
</TR>
<TR><TD VALIGN="TOP" HEIGHT=22>
<FONT FACE="Courier"><P>November 3, 2010</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Courier"><P ALIGN="JUSTIFY"></P>
<P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Exhibit 23(b)</P>
<P ALIGN="CENTER">Analysis, Research &amp; Planning Corporation's Consent</P>
<P ALIGN="CENTER"></P>
<P ALIGN="JUSTIFY">Regarding the Registration Statement on Form S-8 for The Dow Chemical Company 2003-2013 Employees' Stock Purchase Plan (the
&quot;Registration Statement&quot;), Analysis, Research &amp; Planning Corporation (&quot;ARPC&quot;) hereby consents to the incorporation by reference in the Registration Statement of the use of ARPC's name and the reference to ARPC's reports appearing in the Annual Report on Form 10-K of The Dow Chemical Company for the year ended December 31, 2009, and in the Quarterly Reports on Form 10-Q of The Dow Chemical Company for the quarters ended March 31, 2010, June 30, 2010 and September 30, 2010.</P>
<P ALIGN="CENTER"></P>
<U><P>/S/ B. THOMAS FLORENCE</P>
</U><P>B. Thomas Florence</P>
<P>President</P>
<P>Analysis, Research &amp; Planning Corporation</P>
<P>November 3, 2010</P>
<P ALIGN="JUSTIFY"></P>
<U>
</U>
<p ALIGN="CENTER">Exhibit 24</p>
<p ALIGN="CENTER">Power of Attorney</p>
<p ALIGN="JUSTIFY">&nbsp;</p>
<p ALIGN="JUSTIFY">Each person whose signature appears below constitutes and
appoints Ronald C. Edmonds, Charles J. Kalil and William H. Weideman, acting
severally, as his or her attorney-in-fact and agent, to sign one or more
registration statements on Form S-8 and any or all amendments (including
post-effective amendments) to such registration statements in connection with
the registration under the Securities Act of 1933 of shares of the common stock
of The Dow Chemical Company pursuant to the <b>2003-2013 Employees' Stock
Purchase Plan,</b> and to file the same, with all exhibits thereto, and other
documents in connection therewith, with the Securities and Exchange Commission,
granting to said attorney-in-fact and agent full power and authority to perform
any act in connection with any of the foregoing as fully to all intents and
purposes as he or she might do in person, hereby ratifying and confirming all
that said attorney-in-fact and agent may lawfully do or cause to be done by
virtue hereof. Each attorney-in-fact and agent is hereby granted full power of
substitution and revocation with respect hereto.</p>
<u>
<table BORDER CELLSPACING="1" CELLPADDING="9" WIDTH="738" id="table1">
	<tr>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">SIGNATURE</font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">TITLE</font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">DATE</font></td>
	</tr>
	<tr>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier"><u>
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">/S/ A.A. Allemang</p>
		</u><b>
		<p ALIGN="CENTER">A.A. Allemang</b></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">Director </font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">December 10, 2009</font></td>
	</tr>
	<tr>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier"><u>
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">/S/ J.K. Barton</p>
		</u><b>
		<p ALIGN="CENTER">J.K. Barton</b></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">Director</p>
		<p ALIGN="CENTER"></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">December 10, 2009</font></td>
	</tr>
	<tr>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier"><u>
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">/S/ J. A. Bell</p>
		</u><b>
		<p ALIGN="CENTER">J. A. Bell</b></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">Director</font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">December 10, 2009</font></td>
	</tr>
	<tr>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier"><u>
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">/S/ R. C. EDMONDS</p>
		</u><b>
		<p ALIGN="CENTER">R. C. Edmonds</b></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">Vice President and</p>
		<p ALIGN="CENTER">Controller</p>
		<p ALIGN="CENTER">(Principal Accounting Officer)</font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">December 10, 2009</font></td>
	</tr>
	<tr>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier"><u>
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">/S/ J. M. Fettig</p>
		</u><b>
		<p ALIGN="CENTER">J. M. Fettig</b></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">Director</p>
		<p ALIGN="CENTER"></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">December 10, 2009</font></td>
	</tr>
	<tr>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier"><u>
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">/S/ B.H. Franklin</p>
		</u><b>
		<p ALIGN="CENTER">B.H. Franklin</b></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">Director</p>
		<p ALIGN="CENTER"></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">December 10, 2009</font></td>
	</tr>
	<tr>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier"><u>
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">/S/ J. B. Hess</p>
		</u><b>
		<p ALIGN="CENTER">J. B. Hess</b></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">Director</p>
		<p ALIGN="CENTER"></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">December 10, 2009</font></td>
	</tr>
	<tr>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier"><u>
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">/S/ A. N. Liveris</p>
		</u><b>
		<p ALIGN="CENTER">A. N. Liveris</b></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">Director, Chairman, President and Chief Executive
		Officer</font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">December 10, 2009</font></td>
	</tr>
	<tr>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier"><u>
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">/S/ D. H. REILLEY</p>
		</u><b>
		<p ALIGN="CENTER">D. H. Reilley</b></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">Director</font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">December 10, 2009</font></td>
	</tr>
	<tr>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier"><u>
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">/S/ J.M. Ringler</p>
		</u><b>
		<p ALIGN="CENTER">J.M. Ringler</b></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">Director</p>
		<p ALIGN="CENTER"></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">December 10, 2009</font></td>
	</tr>
	<tr>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier"><u>
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">/S/ R. G. Shaw</p>
		</u><b>
		<p ALIGN="CENTER">R. G. Shaw</b></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">Director</font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">December 10, 2009</font></td>
	</tr>
	<tr>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier"><u>
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">/S/ P.G. Stern</p>
		</u><b>
		<p ALIGN="CENTER">P.G. Stern</b></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">Presiding Director</p>
		<p ALIGN="CENTER"></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">December 10, 2009</font></td>
	</tr>
	<tr>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier"><u>
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">/S/ W.H. WEIDEMAN</p>
		</u><b>
		<p ALIGN="CENTER">W. H. Weideman</b></font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">Vice President and Interim Chief Financial Officer</font></td>
		<td WIDTH="33%" VALIGN="TOP"><font FACE="Courier">
		<p ALIGN="CENTER">&nbsp;</p>
		<p ALIGN="CENTER">December 10, 2009</font></td>
	</tr>
</table>
<p ALIGN="CENTER">&nbsp;</p>
</u>
</FONT></BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "seight.htm", "description": "FORM S-8", "secsgml_size_bytes": 33334}]
{"company-data": {"conformed-name": "DOW CHEMICAL CO /DE/", "cik": "0000029915", "assigned-sic": "2821", "irs-number": "381285128", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-170384", "film-number": "101167903"}, "business-address": {"street1": "2030 DOW CENTER", "city": "MIDLAND", "state": "MI", "zip": "48674-2030", "phone": "989-636-1000"}, "mail-address": {"street1": "2030 DOW CENTER", "city": "MIDLAND", "state": "MI", "zip": "48674-2030"}}
Form S-8
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________
Form S-8
REGISTRATION STATEMENT
under
THE SECURITIES ACT OF 1933
____________________
THE DOW CHEMICAL COMPANY
(a Delaware corporation)
Executive Offices -- 2030 Dow Center
Midland, Michigan 48674
(Name, state of incorporation and address of principal executive office of issuer)
I.R.S. Employer Identification No. 38-1285128
____________________
The Dow Chemical Company
2003-2013 Employees' Stock Purchase Plan
(Full title of the plan)
____________________
CHARLES J. KALIL
Executive Vice President, General Counsel
and Corporate Secretary
THE DOW CHEMICAL COMPANY
2030 Dow Center
Midland, Michigan 48674
(Name and address of agent for service)
Telephone:  (989) 636-1000
____________________
CALCULATION OF REGISTRATION FEE
Title
of securities
to be registered
Amount to
be registered
Proposed maximum
offering price
per share
Proposed maximum
aggregate
offering price
Amount of
registration fee
Common Stock, par value $2.50 per share, of The Dow Chemical Company
12,000,000
shares
$25.75
$309,000,000
$22,031.70
PART II
Item 3.  INCORPORATION OF DOCUMENTS BY REFERENCE.
The following documents heretofore filed by The Dow Chemical Company ("Dow") with the Securities and Exchange Commission (the
"Commission") are incorporated herein by this reference:
(a)
Dow's Annual Report on Form 10-K for the year ended December 31, 2009. (The consolidated financial statements and the related financial statement schedule, incorporated by reference from Dow's Annual Report on Form 10-K, filed February 19, 2010, and Dow's internal control over financial reporting have been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their reports, which are incorporated herein by reference.)
(b)  Dow's Quarterly Reports on Form 10-Q for the quarters ended March 31, 2010, June 30, 2010 and September 30, 2010.
(c)  Dow's Current Reports on Form 8-K filed or furnished, as the case may be, on February 2, 2010, February 11, 2010, February 12, 2010, February 18, 2010, February 19, 2010, March 9, 2010, April 28, 2010, May 3, 2010, May 14, 2010, June 10, 2010, August 3, 2010 and October 28, 2010.
(d)	The description of Dow's Common Stock, par value $2.50 per share, contained in a registration statement filed pursuant to Section 12 of the Securities Exchange Act of 1934 (the Act) and any amendments or reports filed for the purpose of updating that description.
All documents subsequently filed by Dow pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Act prior to the filing of a post-effective amendment which indicates that all the securities offered hereby have been sold or which deregisters all such securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents.
Item 5.  INTERESTS OF NAMED EXPERTS AND COUNSEL.
The validity of the issuance of Dow's Common Stock offered hereby has been passed on by Duncan A. Stuart, Associate General Counsel - Corporate Transactions for Dow.  As of November 1, 2010, Mr. Stuart beneficially owned 8,250 deferred stock units and 15.6 shares of Dow common stock pursuant to various employee stock plans; and held options to purchase 71,211 shares of Dow common stock, of which options to purchase 42,256 shares of Dow common stock were exercisable.
Item 6.  INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Under Article VI of the Restated Certificate of Incorporation, as amended, Dow may indemnify its Directors, officers, employees and agents to such extent as is permitted by the laws of the State of Delaware and as Dow's Bylaws may from time to time provide.  Section 145 of the General Corporation Law of the State of Delaware empowers Dow to indemnify, subject to the standards and limitations therein prescribed, any person in connection with any action, suit or proceeding brought or threatened by reason of the fact that such person is or was a Director, officer, employee or agent of Dow or is or was serving as such with respect to another corporation or other enterprise at the request of Dow.  Under Section VI of the Bylaws of Dow, Dow is required to indemnify its Directors, officers and employees to the fullest extent permitted by Delaware law whenever such a person is a defendant in any legal proceeding.  Section VI also gives the Company discretion to indemnify Directors, officers, employees and agents in other legal proceedings to which they are made a party.  Any indemnification of a Director, officer, employee or agent of the Company must be approved by the Board of Directors.  Dow maintains a Directors' and officers' liability insurance policy that indemnifies Dow's Directors and officers against certain losses in connection with claims made against them for certain wrongful acts.
Item 8.  EXHIBITS.
Exhibit No.
Description of Exhibit
4(a)
Restated Certificate of Incorporation of The Dow Chemical Company, filed as Exhibit 3(i) to Dow's Quarterly Report on Form 10-Q for the quarter ended September 30, 2010, incorporated herein by this reference.
4(a)(i)
Certificate of Designations for the Cumulative Convertible Perpetual Preferred Stock, Series A, as originally filed with the Secretary of State, State of Delaware on March 31, 2009, and re-filed on May 17, 2010, incorporated by reference to Exhibit 3.1 to The Dow Chemical Company Current Report on Form 8-K filed on April 1, 2009.
4(b)
Bylaws of The Dow Chemical Company, filed as Exhibit 99.1 to a Form 8-K filed on February 12, 2010, incorporated herein by this reference.
5
Opinion of Counsel
23(a)
Consent of Independent Registered Public Accounting Firm.
23(b)
ARPC's Consent.
23(c)
Consent of Duncan A. Stuart, included in the opinion filed as Exhibit 5.
24
Power of Attorney.
Item 9.  UNDERTAKINGS.
(a)  The undersigned registrant hereby undertakes:
(1)	To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
(i)	To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;
(ii)	To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement; and
(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;
Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.
(2)	That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(3)	To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(b)	The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(c)	Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to Directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable.  In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a Director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such Director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.
SIGNATURES
The Registrant.  Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Midland, State of Michigan, on November 3, 2010.
THE DOW CHEMICAL COMPANY
(Registrant)
By:
/S/ RONALD C. EDMONDS
Ronald C. Edmonds
Vice President and Controller
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.
A. A. ALLEMANG*
A. A. Allemang        Director
J. K. BARTON*
J. K. Barton          Director
J. A. BELL*
J. A. Bell            Director
J. M. FETTIG*
J. M. Fettig          Director
B. H. FRANKLIN*
B. H. Franklin        Director
J. B. HESS*
J. B. Hess            Director
A. N. LIVERIS*
A. N. Liveris         Director, President, Chief Executive Officer and
Chairman
______________
P. Polman             Director
D. H. REILLEY*
D. H. Reilley         Director
J. M. RINGLER*
J. M. Ringler         Director
R. G. SHAW*
R. G. Shaw            Director
P. G. STERN*
P. G. Stern           Presiding Director
/S/ R. C. EDMONDS
R. C. Edmonds         Vice President and Controller
(Principal Accounting Officer)
W. H. WEIDEMAN*
W. H. Weideman        Executive Vice President and Chief Financial Officer
*By:
/S/ RONALD C. EDMONDS
Ronald C. Edmonds
Attorney-in-Fact
November 3, 2010
EXHIBIT INDEX
Exhibit No.
Description of Exhibit
Page Number
4(a)
Restated Certificate of Incorporation of The Dow Chemical Company, filed as Exhibit 3(i) to Dow's Quarterly Report on Form 10-Q for the quarter ended September 30, 2010, incorporated herein by this reference.
4(a)(i)
Certificate of Designations for the Cumulative Convertible Perpetual Preferred Stock, Series A, as originally filed with the Secretary of State, State of Delaware on March 31, 2009, and re-filed on May 17, 2010, incorporated by reference to Exhibit 3.1 to The Dow Chemical Company Current Report on Form 8-K filed on April 1, 2009.
4(b)
Bylaws of The Dow Chemical Company, filed as Exhibit 99.1 to a Form 8-K filed on February 12, 2010, incorporated herein by this reference.
5
Opinion of Counsel
10-11
23(a)
Consent of Independent Registered Public Accounting Firm.
12
23(b)
ARPC's Consent.
13
23(c)
Consent of Duncan A. Stuart, included in the opinion filed as Exhibit 5.
24
Power of Attorney.
14-15
EXHIBIT 5
OPINION OF COUNSEL
November 5, 2010
The Dow Chemical Company
2030 Dow Center
Midland, Michigan  48674
Ladies and Gentlemen:
I am Associate General Counsel - Corporate Transactions of The Dow Chemical Company, a Delaware corporation (the
"Company").  Reference is hereby made to the Registration Statement on Form S-8 filed by the Company on the date hereof with the Securities and Exchange Commission, relating to the registration of
12 million shares of the Company's common stock, par value $2.50 per share (the
"Common Stock"), for The Dow Chemical Company 2003-2013 Employees' Stock Purchase Plan (the
"Plan").
In rendering the opinions expressed below, I have supervised the examination of: (a) the Restated Certificate of Incorporation of the Company and all amendments thereto; (b) the Bylaws of the Company and all amendments thereto; (c) the Registration Statement on Form S-8; (d) resolutions of the Board of Directors of the Company; and (e) such other documents, corporate records and instruments as I have deemed necessary or advisable for the purpose of this opinion.
Based on the foregoing, and subject to the qualifications hereinafter set forth, it is my opinion that:
1. The Company is duly organized and existing under the laws of the State of Delaware; and
2. The Common Stock to be issued pursuant to the Plan is duly authorized for issuance and, when issued and delivered, will be legally issued, fully paid and nonassessable.
I do not express any opinion concerning matters under or involving any law other than the law of the State of Michigan, the General Corporation Law of the State of Delaware and applicable federal law of the United States of America.  The opinions expressed herein are based upon the laws in effect on the date hereof, and I assume no obligation to revise or supplement this opinion should such laws be changed by legislative action, judicial decision or otherwise.
I hereby consent to the filing of this opinion as an exhibit to the Company's Registration Statement on Form S-8 and to the reference to me under the caption
"Interests of Named Experts and Counsel in the Registration Statement".
Very truly yours,
/S/ DUNCAN A. STUART
Duncan A. Stuart
Associate General Counsel -
Corporate Transactions
The Dow Chemical Company
EXHIBIT 23(a)
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports dated February 19, 2010, relating to the financial statements and financial statement schedule of The Dow Chemical Company and subsidiaries (the
"Company"), and the effectiveness of the Company's internal control over financial reporting, appearing in the Annual Report on Form 10-K of The Dow Chemical Company for the year ended December 31, 2009.
/S/ DELOITTE & TOUCHE LLP
Midland, Michigan
November 3, 2010
Exhibit 23(b)
Analysis, Research & Planning Corporation's Consent
Regarding the Registration Statement on Form S-8 for The Dow Chemical Company 2003-2013 Employees' Stock Purchase Plan (the
"Registration Statement"), Analysis, Research & Planning Corporation ("ARPC") hereby consents to the incorporation by reference in the Registration Statement of the use of ARPC's name and the reference to ARPC's reports appearing in the Annual Report on Form 10-K of The Dow Chemical Company for the year ended December 31, 2009, and in the Quarterly Reports on Form 10-Q of The Dow Chemical Company for the quarters ended March 31, 2010, June 30, 2010 and September 30, 2010.
/S/ B. THOMAS FLORENCE
B. Thomas Florence
President
Analysis, Research & Planning Corporation
November 3, 2010
Exhibit 24
Power of Attorney
Each person whose signature appears below constitutes and
appoints Ronald C. Edmonds, Charles J. Kalil and William H. Weideman, acting
severally, as his or her attorney-in-fact and agent, to sign one or more
registration statements on Form S-8 and any or all amendments (including
post-effective amendments) to such registration statements in connection with
the registration under the Securities Act of 1933 of shares of the common stock
of The Dow Chemical Company pursuant to the
2003-2013 Employees' Stock
Purchase Plan,
and to file the same, with all exhibits thereto, and other
documents in connection therewith, with the Securities and Exchange Commission,
granting to said attorney-in-fact and agent full power and authority to perform
any act in connection with any of the foregoing as fully to all intents and
purposes as he or she might do in person, hereby ratifying and confirming all
that said attorney-in-fact and agent may lawfully do or cause to be done by
virtue hereof. Each attorney-in-fact and agent is hereby granted full power of
substitution and revocation with respect hereto.
SIGNATURE
TITLE
DATE
/S/ A.A. Allemang
A.A. Allemang
Director
December 10, 2009
/S/ J.K. Barton
J.K. Barton
Director
December 10, 2009
/S/ J. A. Bell
J. A. Bell
Director
December 10, 2009
/S/ R. C. EDMONDS
R. C. Edmonds
Vice President and
Controller
(Principal Accounting Officer)
December 10, 2009
/S/ J. M. Fettig
J. M. Fettig
Director
December 10, 2009
/S/ B.H. Franklin
B.H. Franklin
Director
December 10, 2009
/S/ J. B. Hess
J. B. Hess
Director
December 10, 2009
/S/ A. N. Liveris
A. N. Liveris
Director, Chairman, President and Chief Executive
		Officer
December 10, 2009
/S/ D. H. REILLEY
D. H. Reilley
Director
December 10, 2009
/S/ J.M. Ringler
J.M. Ringler
Director
December 10, 2009
/S/ R. G. Shaw
R. G. Shaw
Director
December 10, 2009
/S/ P.G. Stern
P.G. Stern
Presiding Director
December 10, 2009
/S/ W.H. WEIDEMAN
W. H. Weideman
Vice President and Interim Chief Financial Officer
December 10, 2009